Characterization of the Pharmacokinetics of Vilaprisan: Bioavailability, Excretion, Biotransformation, and Drug–Drug Interaction Potential
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1179-1926
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Characterization of the Pharmacokinetics of Vilaprisan: Bioavailability, Excretion, Biotransformation, and Drug–Drug Interaction Potential ; day:12 ; month:1 ; year:2018 ; pages:1-15
Clinical pharmacokinetics ; (12.1.2018), 1-15
- Schlagwort
-
Biopharmazie
Pharmakodynamik
Pharmakokinetik
- Urheber
-
Schultze-Mosgau, Marcus-Hillert
- Beteiligte Personen und Organisationen
-
Höchel, Joachim
Prien, Olaf
Zimmermann, Torsten
Brooks, Ashley
Bush, Jim
Rottmann, Antje
SpringerLink (Online service)
- DOI
-
10.1007/s40262-017-0607-4
- URN
-
urn:nbn:de:1111-201803163229
- Rechteinformation
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.08.2025, 10:58 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Schultze-Mosgau, Marcus-Hillert
- Höchel, Joachim
- Prien, Olaf
- Zimmermann, Torsten
- Brooks, Ashley
- Bush, Jim
- Rottmann, Antje
- SpringerLink (Online service)
Ähnliche Objekte (12)
A Review of Daclatasvir Drug–Drug Interactions
Drug–Drug Interactions with Direct Oral Anticoagulants
Extracting drug-drug interactions from biomedical texts
Delta-9-Tetrahydrocannabinol and Cannabidiol Drug-Drug Interactions
Case report: Medical cannabis—warfarin drug-drug interaction
Lurasidone drug-drug interaction studies: a comprehensive review
DPDDI: a deep predictor for drug-drug interactions
Pharmacovigilance of Drug–Drug Interactions with Nirmatrelvir/Ritonavir
Evaluating drug-drug interaction information in NDF-RT and DrugBank
A Minimal Information Model for Potential Drug-Drug Interactions
Drug-drug interactions. Things to do in pain management
Drug−Drug Interactions Involving Intestinal and Hepatic CYP1A Enzymes
A Review of Daclatasvir Drug–Drug Interactions
Drug–Drug Interactions with Direct Oral Anticoagulants
Extracting drug-drug interactions from biomedical texts
Delta-9-Tetrahydrocannabinol and Cannabidiol Drug-Drug Interactions
Case report: Medical cannabis—warfarin drug-drug interaction
Lurasidone drug-drug interaction studies: a comprehensive review
DPDDI: a deep predictor for drug-drug interactions
Pharmacovigilance of Drug–Drug Interactions with Nirmatrelvir/Ritonavir
Evaluating drug-drug interaction information in NDF-RT and DrugBank
A Minimal Information Model for Potential Drug-Drug Interactions
Drug-drug interactions. Things to do in pain management
Drug−Drug Interactions Involving Intestinal and Hepatic CYP1A Enzymes
A Review of Daclatasvir Drug–Drug Interactions
Drug–Drug Interactions with Direct Oral Anticoagulants
Extracting drug-drug interactions from biomedical texts
Delta-9-Tetrahydrocannabinol and Cannabidiol Drug-Drug Interactions
Case report: Medical cannabis—warfarin drug-drug interaction
Lurasidone drug-drug interaction studies: a comprehensive review
DPDDI: a deep predictor for drug-drug interactions
Pharmacovigilance of Drug–Drug Interactions with Nirmatrelvir/Ritonavir
Evaluating drug-drug interaction information in NDF-RT and DrugBank
A Minimal Information Model for Potential Drug-Drug Interactions
Drug-drug interactions. Things to do in pain management